Click for best price
Next Generation Diabetes Therapy Drug Delivery Market Size, Share 2024
| Market size in 2023 |
US$ 1657.9 million
|
Forecast Market size by 2030 |
US$ 7861.7 million
|
| Growth Rate |
CAGR of 24.5% |
Number of Pages |
127 Pages |
This research report provides a comprehensive analysis of the Next Generation Diabetes Therapy and Drug Delivery market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Next Generation Diabetes Therapy and Drug Delivery market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Next Generation Diabetes Therapy and Drug Delivery, challenges faced by the industry, and potential opportunities for market players.
The global Next Generation Diabetes Therapy and Drug Delivery market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Next Generation Diabetes Therapy and Drug Delivery market presents opportunities for various stakeholders, including Diagnostic/Clinics, ICUs. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Next Generation Diabetes Therapy and Drug Delivery market. Additionally, the growing consumer demand present avenues for market expansion.
The global Next Generation Diabetes Therapy and Drug Delivery market was valued at US$ 1657.9 million in 2023 and is projected to reach US$ 7861.7 million by 2030, at a CAGR of 24.5% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Next Generation Diabetes Therapy and Drug Delivery market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Next Generation Diabetes Therapy and Drug Delivery market.
Market Overview: The report provides a comprehensive overview of the Next Generation Diabetes Therapy and Drug Delivery market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Inhalable Insulin, Oral Insulin), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Next Generation Diabetes Therapy and Drug Delivery market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Next Generation Diabetes Therapy and Drug Delivery market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Next Generation Diabetes Therapy and Drug Delivery market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Next Generation Diabetes Therapy and Drug Delivery market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Next Generation Diabetes Therapy and Drug Delivery market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Next Generation Diabetes Therapy and Drug Delivery market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Next Generation Diabetes Therapy and Drug Delivery, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Next Generation Diabetes Therapy and Drug Delivery market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
- Next Generation Diabetes Therapy and Drug Delivery market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Inhalable Insulin
- Oral Insulin
- Insulin Patches
- CGM Systems
- Artificial Pancreas
Market segment by Application
- Diagnostic/Clinics
- ICUs
- Home Healthcare
Global Next Generation Diabetes Therapy and Drug Delivery Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
- Johnson & Johnson
- Abbott Laboratories
- Medtronic
- Sanofi
- Novo Nordisk
- MannKind Corporation
- Enteris BioPharma
- Dexcom
- Senseonics
- Medtech
- Synertech
- Zosano Pharma
- Relmada Therapeutics
- Eli Lilly and Company
- Transdermal Specialties
Outline of Major Chapters:
Chapter 1: Introduces the definition of Next Generation Diabetes Therapy and Drug Delivery, market overview.
Chapter 2: Global Next Generation Diabetes Therapy and Drug Delivery market size in revenue.
Chapter 3: Detailed analysis of Next Generation Diabetes Therapy and Drug Delivery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Next Generation Diabetes Therapy and Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Next Generation Diabetes Therapy and Drug Delivery Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 1657.9 million
|
| Forecast Market size by 2030 |
US$ 7861.7 million
|
| Growth Rate |
CAGR of 24.5% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
127 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Next Generation Diabetes Therapy and Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Next Generation Diabetes Therapy and Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Next Generation Diabetes Therapy and Drug Delivery Overall Market Size
2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size: 2023 VS 2030
2.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Next Generation Diabetes Therapy and Drug Delivery Players in Global Market
3.2 Top Global Next Generation Diabetes Therapy and Drug Delivery Companies Ranked by Revenue
3.3 Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Next Generation Diabetes Therapy and Drug Delivery Companies in Global Market, by Revenue in 2023
3.5 Global Companies Next Generation Diabetes Therapy and Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Next Generation Diabetes Therapy and Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Next Generation Diabetes Therapy and Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Next Generation Diabetes Therapy and Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Next Generation Diabetes Therapy and Drug Delivery Market Size Markets, 2023 & 2030
4.1.2 Inhalable Insulin
4.1.3 Oral Insulin
4.1.4 Insulin Patches
4.1.5 CGM Systems
4.1.6 Artificial Pancreas
4.2 By Type - Global Next Generation Diabetes Therapy and Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2019-2024
4.2.2 By Type - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2025-2030
4.2.3 By Type - Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Next Generation Diabetes Therapy and Drug Delivery Market Size, 2023 & 2030
5.1.2 Diagnostic/Clinics
5.1.3 ICUs
5.1.4 Home Healthcare
5.2 By Application - Global Next Generation Diabetes Therapy and Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2019-2024
5.2.2 By Application - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2025-2030
5.2.3 By Application - Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Next Generation Diabetes Therapy and Drug Delivery Market Size, 2023 & 2030
6.2 By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2019-2024
6.2.2 By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2025-2030
6.2.3 By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Next Generation Diabetes Therapy and Drug Delivery Revenue, 2019-2030
6.3.2 US Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
6.3.3 Canada Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
6.3.4 Mexico Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Next Generation Diabetes Therapy and Drug Delivery Revenue, 2019-2030
6.4.2 Germany Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
6.4.3 France Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
6.4.4 U.K. Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
6.4.5 Italy Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
6.4.6 Russia Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
6.4.7 Nordic Countries Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
6.4.8 Benelux Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Next Generation Diabetes Therapy and Drug Delivery Revenue, 2019-2030
6.5.2 China Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
6.5.3 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
6.5.4 South Korea Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
6.5.5 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
6.5.6 India Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Next Generation Diabetes Therapy and Drug Delivery Revenue, 2019-2030
6.6.2 Brazil Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
6.6.3 Argentina Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Revenue, 2019-2030
6.7.2 Turkey Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
6.7.3 Israel Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
6.7.4 Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
6.7.5 UAE Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
7 Next Generation Diabetes Therapy and Drug Delivery Companies Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.1.4 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Company Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.2.4 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
7.2.5 Abbott Laboratories Key News & Latest Developments
7.3 Medtronic
7.3.1 Medtronic Company Summary
7.3.2 Medtronic Business Overview
7.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.3.4 Medtronic Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
7.3.5 Medtronic Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.4.4 Sanofi Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
7.4.5 Sanofi Key News & Latest Developments
7.5 Novo Nordisk
7.5.1 Novo Nordisk Company Summary
7.5.2 Novo Nordisk Business Overview
7.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.5.4 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
7.5.5 Novo Nordisk Key News & Latest Developments
7.6 MannKind Corporation
7.6.1 MannKind Corporation Company Summary
7.6.2 MannKind Corporation Business Overview
7.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.6.4 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
7.6.5 MannKind Corporation Key News & Latest Developments
7.7 Enteris BioPharma
7.7.1 Enteris BioPharma Company Summary
7.7.2 Enteris BioPharma Business Overview
7.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.7.4 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
7.7.5 Enteris BioPharma Key News & Latest Developments
7.8 Dexcom
7.8.1 Dexcom Company Summary
7.8.2 Dexcom Business Overview
7.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.8.4 Dexcom Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
7.8.5 Dexcom Key News & Latest Developments
7.9 Senseonics
7.9.1 Senseonics Company Summary
7.9.2 Senseonics Business Overview
7.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.9.4 Senseonics Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
7.9.5 Senseonics Key News & Latest Developments
7.10 Medtech
7.10.1 Medtech Company Summary
7.10.2 Medtech Business Overview
7.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.10.4 Medtech Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
7.10.5 Medtech Key News & Latest Developments
7.11 Synertech
7.11.1 Synertech Company Summary
7.11.2 Synertech Business Overview
7.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.11.4 Synertech Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
7.11.5 Synertech Key News & Latest Developments
7.12 Zosano Pharma
7.12.1 Zosano Pharma Company Summary
7.12.2 Zosano Pharma Business Overview
7.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.12.4 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
7.12.5 Zosano Pharma Key News & Latest Developments
7.13 Relmada Therapeutics
7.13.1 Relmada Therapeutics Company Summary
7.13.2 Relmada Therapeutics Business Overview
7.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.13.4 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
7.13.5 Relmada Therapeutics Key News & Latest Developments
7.14 Eli Lilly and Company
7.14.1 Eli Lilly and Company Company Summary
7.14.2 Eli Lilly and Company Business Overview
7.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.14.4 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
7.14.5 Eli Lilly and Company Key News & Latest Developments
7.15 Transdermal Specialties
7.15.1 Transdermal Specialties Company Summary
7.15.2 Transdermal Specialties Business Overview
7.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.15.4 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
7.15.5 Transdermal Specialties Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Next Generation Diabetes Therapy and Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Next Generation Diabetes Therapy and Drug Delivery Market Drivers in Global Market
Table 3. Next Generation Diabetes Therapy and Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Next Generation Diabetes Therapy and Drug Delivery in Global Market
Table 5. Top Next Generation Diabetes Therapy and Drug Delivery Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Companies, 2019-2024
Table 8. Global Companies Next Generation Diabetes Therapy and Drug Delivery Product Type
Table 9. List of Global Tier 1 Next Generation Diabetes Therapy and Drug Delivery Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Next Generation Diabetes Therapy and Drug Delivery Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2025-2030
Table 30. Johnson & Johnson Company Summary
Table 31. Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 32. Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2019-2024)
Table 33. Johnson & Johnson Key News & Latest Developments
Table 34. Abbott Laboratories Company Summary
Table 35. Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 36. Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2019-2024)
Table 37. Abbott Laboratories Key News & Latest Developments
Table 38. Medtronic Company Summary
Table 39. Medtronic Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 40. Medtronic Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2019-2024)
Table 41. Medtronic Key News & Latest Developments
Table 42. Sanofi Company Summary
Table 43. Sanofi Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 44. Sanofi Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2019-2024)
Table 45. Sanofi Key News & Latest Developments
Table 46. Novo Nordisk Company Summary
Table 47. Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 48. Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2019-2024)
Table 49. Novo Nordisk Key News & Latest Developments
Table 50. MannKind Corporation Company Summary
Table 51. MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 52. MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2019-2024)
Table 53. MannKind Corporation Key News & Latest Developments
Table 54. Enteris BioPharma Company Summary
Table 55. Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 56. Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2019-2024)
Table 57. Enteris BioPharma Key News & Latest Developments
Table 58. Dexcom Company Summary
Table 59. Dexcom Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 60. Dexcom Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2019-2024)
Table 61. Dexcom Key News & Latest Developments
Table 62. Senseonics Company Summary
Table 63. Senseonics Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 64. Senseonics Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2019-2024)
Table 65. Senseonics Key News & Latest Developments
Table 66. Medtech Company Summary
Table 67. Medtech Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 68. Medtech Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2019-2024)
Table 69. Medtech Key News & Latest Developments
Table 70. Synertech Company Summary
Table 71. Synertech Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 72. Synertech Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2019-2024)
Table 73. Synertech Key News & Latest Developments
Table 74. Zosano Pharma Company Summary
Table 75. Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 76. Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2019-2024)
Table 77. Zosano Pharma Key News & Latest Developments
Table 78. Relmada Therapeutics Company Summary
Table 79. Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 80. Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2019-2024)
Table 81. Relmada Therapeutics Key News & Latest Developments
Table 82. Eli Lilly and Company Company Summary
Table 83. Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 84. Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2019-2024)
Table 85. Eli Lilly and Company Key News & Latest Developments
Table 86. Transdermal Specialties Company Summary
Table 87. Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 88. Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2019-2024)
Table 89. Transdermal Specialties Key News & Latest Developments
List of Figures
Figure 1. Next Generation Diabetes Therapy and Drug Delivery Segment by Type in 2023
Figure 2. Next Generation Diabetes Therapy and Drug Delivery Segment by Application in 2023
Figure 3. Global Next Generation Diabetes Therapy and Drug Delivery Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Next Generation Diabetes Therapy and Drug Delivery Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2023
Figure 8. By Type - Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2019-2030
Figure 9. By Application - Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2019-2030
Figure 10. By Type - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2019-2030
Figure 12. By Application - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2019-2030
Figure 14. By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2019-2030
Figure 15. By Country - North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2019-2030
Figure 16. US Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2019-2030
Figure 20. Germany Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 21. France Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2019-2030
Figure 28. China Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 32. India Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2019-2030
Figure 34. Brazil Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2019-2030
Figure 37. Turkey Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 41. Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Medtronic Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Sanofi Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Dexcom Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Senseonics Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Medtech Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Synertech Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
